Millstone Evans Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$164K Buy
421
+2
+0.5% +$846 0.09% 173
2026
Q1
$198K Hold
419
0.12% 142
2025
Q4
$196K Hold
419
0.12% 142
2025
Q3
$179K Hold
419
0.11% 141
2025
Q2
$161K Hold
419
0.11% 146
2025
Q1
$145K Hold
419
0.1% 152
2024
Q4
$126K Buy
+419
New +$146K 0.09% 161

Other funds holding HCA

Millstone Evans Group's HCA Position: Q2 2026 in Review

Millstone Evans Group increased its HCA Healthcare (HCA) stake by 0.48% in Q2 2026, buying an estimated $846 and bringing the position to 421 shares worth $164K. The position accounts for 0.09% of the portfolio, ranked #173.

Millstone Evans Group first reported a position in HCA in Q4 2024 and has held it in 7 quarters since. The position peaked at $198K in Q1 2026. 1,094 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Millstone Evans Group held 421 shares of HCA Healthcare worth $164K as of Q2 2026.
  • Millstone Evans Group bought 2 HCA Healthcare shares in Q2 2026, an estimated $846.
  • HCA Healthcare made up 0.09% of Millstone Evans Group's portfolio in Q2 2026, its #173 holding.
  • Millstone Evans Group first reported a position in HCA Healthcare in Q4 2024 and has held it in 7 quarters since.
  • Millstone Evans Group's HCA Healthcare position peaked at $198K in Q1 2026.
  • 1,094 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.